The lateral ventricle (LV) is a preferential location for brain tumor spread; however, the instructive cues responsible for this unique tropism were previously unknown. In this issue, Qin et al. elucidate the underlying mechanism, demonstrating that LV-neural progenitors secrete a pleiotrophin (PTN)-containing complex, which attracts glioma cells through ROCK/Rho activation.
While whole-tumor genomic landscaping initiatives and single-cell sequencing studies have highlighted the importance of neoplastic cell driver mutations in oncogenesis, it is becoming increasingly evident that non-neoplastic cell contributions are also critical for tumor formation and progression. This concept is reinforced by the analysis of cancer predisposition syndromes, where the interplay of germline and somatic mutations partly determines tumor development, but other factors interact to specify phenotypic expression and clinical progression. In this regard, individuals with neurofibromatosis type 1 (NF1) are prone to brain tumor (glioma) development; however, only a small fraction of affected persons (15%-20%) develop gliomas, the majority of which arise in defined brain regions (optic pathway gliomas [OPGs] , brainstem) of young children (mean age, 4.5 years), and fewer than half of patients with NF1-OPGs exhibit clinical symptoms from their tumors (vision loss). These observations indicate a requirement for numerous co-aligning conditions involving both tumor-cell-intrinsic and -extrinsic constraints and also support a model in which spatial and temporally restricted environmental (stromal) cues dictate brain tumor patterning and behavior (Pong and Gutmann, 2011) . Extending discoveries made in these syndromic cancers, studies in sporadic tumors have shown that stromal signals emanating from non-neoplastic cells in the tumor microenvironment, such as immune system cells (dendritic cells, microglia, macrophages), establish a supportive niche for tumor development and growth (Quail and Joyce, 2017) . In addition to these stromal contributors, it is likely that other non-neoplastic cell populations influence brain tumor (glioma) behavior, including neoplastic cell spread within the brain, where stereotypic patterns of parenchymal invasion are observed. Using converging approaches, Monje and colleagues now unravel the molecular and cellular etiologies underlying glioma cell homing and tracking to one region of the brain: the lateral ventricle subventricular zone (LV-SVZ) (Qin et al., 2017, this issue of Cell) .
In this elegant report, Qin et al. (2017) explore the idea that the patterning of glioma spread along the LV-SVZ requires chemoattractive signals that emanate from neural progenitors (NPs) residing within that specific brain region. Whereas conditioned medium from NPs isolated from the LV-SVZ strongly promoted the migration of diffuse intrinsic pontine glioma (DIPG) tumor cells in vitro, conditioned medium from NPs that derive from comparable zones along the third and fourth ventricles were less effective. Based on this tropism, they employed size fractionation and proteomic discovery strategies to isolate a four protein complex in the LV-SVZ NP secretome containing pleiotrophin (PTN). Consistent with a critical role for PTN in mediating the directional migration to NPs in the LV-SVZ, PTN was enriched in LV-SVZ NPs in both mouse and human brain sections. Using genetic and pharmacologic inhibitor approaches in vitro and in vivo, an obligate role for PTN in DIPG spread was established, in which PTN receptor (PTPRZ) engagement was found to be responsible for the migration and homing of DIPG cells to the LV-SVZ through activation of ROCK/Rho pathway signaling. Importantly, while PTN was the most abundantly expressed protein in LV-SVZ NP conditioned medium, maximal chemoattraction required that PTN be physically coupled to three other proteins: secreted protein acidic and rich in cysteine (SPARC), SPARC-like protein-1 (SPARCL1), and heat shock protein 90B (HSP90B). These PTN-binding partners likely work in concert with PTN to promote DIPG migration by acting as metastatic factors that operate through extracellular matrix remodeling (SPARC, SPARCL1) or by functioning as a molecular chaperone to reduce PTN degradation (HSP90B). As such, targeting PTN stability by blocking HSP90B expression decreased the number of DIPG cells invading the LV-SVZ in orthotopically xenografted mice. Taken together, these findings provide a satisfying cellular and molecular model for conceptualizing the unique tropism of glioma cells to this particular brain location and suggest future therapeutic approaches designed to limit glioma spread.
The novel observations reported by Qin et al. (2017) are exciting for several reasons (Figure 1) . First, they reinforce the central role of PTN in glioma biology. Beyond its ability to direct tumor migration, PTN is also expressed by malignant glioma-associated monocytes (microglia/macrophages), where it can promote tumor growth through paracrine PTN-PTPRZ1 signaling (Shi et al., 2017) . In addition, high-grade glioma cells themselves produce PTN to increase tumor proliferation through autocrine mechanisms, as well as to increase endothelial cell proliferation and angiogenesis to provide a supportive niche for glioma expansion (Zhang et al., 2015) . Second, the fact that PTN expression by non-neoplastic brain cells strongly influences tumor migration and spread provides additional evidence that nonneoplastic cells and signals are critical drivers of brain tumor biology and clinical behavior. In this regard, gliomaassociated microglia/macrophages have emerged as essential determinants of glioma formation and maintenance (reviewed in Hambardzumyan et al., 2016) . The importance of these monocytic cells is further underscored by numerous studies demonstrating an obligate role for microglia/macrophages in establishing the fertile soil that facilitates gliomagenesis (Pong et al., 2013) and continued tumor growth (Pyonteck et al., 2013) in low-grade and high-grade glioma genetically engineered mouse models. In addition to tumor-associated monocytes, neurons must also be considered as key stromal contributors to glioma growth. As such, neuronal activity is associated with increased production of secreted factors that promote carcinogenesis. In the brain, neuroligin-3 (NLGN3) expression accompanies increased neuronal activity (Venkatesh et al., 2015) , which heightens glioma growth, whereas within the gastrointestinal stem cell niche, tuft cells produce acetylcholine to induce neuronal nerve growth factor (NGF) expression, creating a feed-forward circuit that expands the enteric nerve population and promotes gastric tumorigenesis (Hayakawa et al., 2017) .
Finally, the current work builds upon findings in other cancers that argue that tumor spread and metastasis is an active process guided by specific cues. In this regard, hematopoietic cell expression of proteinase-3 serves as a homing signal for RAGE-expressing prostate cancer cells to infiltrate and colonize the bone marrow (Kolonin et al., 2017) . The idea that non-neoplastic cells are not merely first-responders to cancer, but are also instructive mediators of tumor biology, highlights their importance as therapeutic targets to limit neoplastic expansion and spread. As the molecular signals that govern tumor spread within tissues and to distant anatomical sites become more completely elucidated, future therapeutic strategies might be harnessed to keep cancer limited to a local disease.
Figure 1. The Complex Cellular and Molecular Interdependences in Brain Tumors
Emerging evidence from numerous laboratories has revealed that brain tumor (glioma) cells respond to signals from non-neoplastic cells in the tumor microenvironment. These molecular instructions are critical for glioma growth, chemoresistance, and spread within the brain. For example, neurons promote glioma expansion in an activity-dependent manner by elaborating neuroligin-3 (NLGN3), while microglia recruited to the tumor secrete growth factors, cytokines/chemokines, and inflammatory mediators (''gliomagens'') that stimulate glioma proliferation. One of these signaling molecules, pleiotrophin (PTN), has been implicated in numerous processes critical for glioma biology. As such, PTN produced by glioma cells can positively regulate tumor growth in an autocrine fashion, as well as drive angiogenesis to provide a supportive microenvironment for glioma cells (perivascular niche). In addition, PTN is also made by glioma-associated monocytes (microglia and macrophages), where it promotes tumor growth. The newest role for PTN was discovered in the current study, where neural progenitors (NPs) in the lateral ventricle subventricular zone (LV-SVZ) secrete a multimeric protein complex, containing PTN, SPARC, SPARCL1, and HSP90B, which collectively establishes a chemoattractive gradient to facilitate the directional migration of glioma cells to this unique brain location.
